Related Experiment Videos
Proton MR spectroscopy in Lesch-Nyhan disease
1Department of Psychiatry and Behavioral Sciences, University of California, Los Angeles 90024, USA.
AJNR. American Journal of Neuroradiology
|May 12, 1998
Summary
Lesch-Nyhan disease patients show reduced N-acetylaspartate and glutamate/glutamine in the prefrontal cortex, suggesting axonal loss. Further research is needed on cortical glutamate/glutamine levels.
Area of Science:
- Neuroscience
- Metabolic Disorders
Background:
- Lesch-Nyhan disease is a rare genetic disorder.
- Neuroimaging studies in Lesch-Nyhan disease are limited.
Purpose of the Study:
- To investigate in vivo brain metabolite changes in Lesch-Nyhan disease patients.
- To compare prefrontal cortex and striatal metabolite levels between patients and controls.
Main Methods:
- Proton magnetic resonance spectroscopy (MRS) was used.
- MRS data were acquired from the prefrontal cortex and striatum.
- Four Lesch-Nyhan disease patients and four age/sex-matched controls were studied.
Main Results:
- Patients exhibited decreased N-acetylaspartate and glutamate/glutamine in the prefrontal cortex.
- No significant metabolite changes were observed in the striatum.
- The findings suggest prefrontal axonal loss in Lesch-Nyhan disease.
Conclusions:
- Proton MRS reveals specific prefrontal cortex metabolite alterations in Lesch-Nyhan disease.
- Reduced N-acetylaspartate and glutamate/glutamine may indicate axonal damage.
- Cortical glutamate/glutamine findings warrant further investigation and may challenge existing cytopathologic models.